Home Page Register login
Untitled Document

 
 
 

 
Wednesday October 10, 2007
1:00 pm-6:00 pm 
BOSTON MARRIOTT, NEWTON, MA
 
This symposium is FREE for participants of the 5th WCIRS
(select this session when registering for main session)
 
Click here to register ONLY for this session ($80)
 
Program
Chair:Arun Sanyal, MD
1:00 pm 
Opening Remarks 
Arun Sanyal, MD 
Yehuda Handelsman,MD 
 
SESSION ONE 
1:05 pm
Nonalcoholic fatty liver: inconsequential finding or silent killer
Mary Rinella, MD
 
1:30 pm
Nonalcoholic steatohepatitis: disease progression and contribution to mortality 
Arthur McCullough, MD
 
1:55 pm
Can NAFLD be diagnosed, graded and staged without a liver biopsy?
Detlief Schuppan,MD PhD
 
2:20 pm-
2:30 pm
Question and Answers Panel Discussion
 
 
 
SPECIAL LECTURE
2:30 pm
NAFLD: Update on Pathogenesis 
Arun J Sanyal, MD
 
3:00 pm- 3:30pm 
Refreshment Break 
 
 
 
SESSION TWO
3:30pm
Treatment of NAFLD:Is bariatrics the answer?
Mary Rinella , MD
 
3:55 pm
Glitazones for NASH: magic bullet or double edged sword? 
Steven Harrison, MD
 
4:20 pm
Emerging therapies for NAFLD 
Arun J Sanyal, MD
 
4:45 pm-
5:00 pm
Question and Answers Panel Discussion
 
 
 
POINT COUNTER POINT 
 
Chair:Arun Sanyal, MD
Is it time to screen the population at risk for NAFLD?
5:00pm 
Yes:Steven Harrison, MD
 
5:15pm
No:Arthur McCullough, MD
 
5:30pm
Question and Answer Panel Discussion
 
 
 
This is a CME activity
Physicians-Int Physicians-Nurses-Pharmacists-Physician Assistants-Dietitians 
 
 
 
  
Jointly Sponsored by
-PESI LLC -Aspen CME services
-Metabolic Endocrine Education Foundation
Partially Supported by
Ethicon-Endosurgery
 
Administrated by
The Metabolic Institute of America
 
 
 
In association with
5th Annual World Congress
on the
Insulin Resistance Syndrome
Endorsed by
-American Association for Study of Liver Diseases (AASLD)
-European Association for the Study of Liver Disease (EASL)
 
 
 
 
   © InsulinResistance.us